2022. Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy. Journal of Analytical Oncology. 11, (Oct. 2022), 40–44. DOI:https://doi.org/10.30683/1927-7229.2022.11.06.